BIOHAVEN PHARMACTL HLDG CO L's ticker is and the CUSIP is G11196905. A total of 4 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,091,000 | +59.6% | 86,600 | +53.8% | 0.03% | +100.0% |
| Q2 2022 | $8,203,000 | +302.3% | 56,300 | +227.3% | 0.01% | +550.0% |
| Q1 2022 | $2,039,000 | -30.9% | 17,200 | -19.6% | 0.00% | 0.0% |
| Q4 2021 | $2,949,000 | -63.6% | 21,400 | -63.3% | 0.00% | -77.8% |
| Q3 2021 | $8,098,000 | +113.9% | 58,300 | +49.5% | 0.01% | +80.0% |
| Q2 2021 | $3,786,000 | +40.2% | 39,000 | -1.3% | 0.01% | +25.0% |
| Q1 2021 | $2,700,000 | -50.4% | 39,500 | -37.8% | 0.00% | -55.6% |
| Q4 2020 | $5,443,000 | +49.8% | 63,500 | +13.6% | 0.01% | -18.2% |
| Q3 2020 | $3,634,000 | +13.7% | 55,900 | +27.9% | 0.01% | -26.7% |
| Q2 2020 | $3,195,000 | -7.0% | 43,700 | -56.7% | 0.02% | -46.4% |
| Q1 2020 | $3,437,000 | -63.7% | 101,000 | -41.9% | 0.03% | -56.2% |
| Q4 2019 | $9,456,000 | +36.6% | 173,700 | +4.7% | 0.06% | +14.3% |
| Q3 2019 | $6,921,000 | -7.2% | 165,900 | -2.6% | 0.06% | -16.4% |
| Q2 2019 | $7,457,000 | +7.5% | 170,300 | +26.3% | 0.07% | -13.0% |
| Q1 2019 | $6,938,000 | +38.9% | 134,800 | -0.2% | 0.08% | +79.1% |
| Q4 2018 | $4,996,000 | +2410.6% | 135,100 | +2449.1% | 0.04% | +2050.0% |
| Q3 2018 | $199,000 | -69.1% | 5,300 | -78.8% | 0.00% | -66.7% |
| Q1 2018 | $644,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 21,400 | $2,949,000 | 0.00% |
| SIMPLEX TRADING, LLC | 6,100 | $840,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |